Epidermal Growth Factor Receptor (EGFR) expression, for instance, together with EGFR mutation status can be used to predict response to existing anti-EGFR treatments in patients with lung cancers (Pao et al., 2004; Mascaux et al., 2011). Here, EGFR is linked to lung cancer.